Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print December 11, 2002.
Biol Reprod 2002, 10.1095/biolreprod.102.012013
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/5/1620    most recent
biolreprod.102.012013v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, G.
Right arrow Articles by O'Brien, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, G.
Right arrow Articles by O'Brien, D. A.
Agricola
Right arrow Articles by Yang, G.
Right arrow Articles by O'Brien, D. A.
BIOLOGY OF REPRODUCTION 68, 1620–1630 (2003)
DOI: 10.1095/biolreprod.102.012013
© 2003 by the Society for the Study of Reproduction, Inc.


Testis

Analysis of Germ Cell Nuclear Factor Transcripts and Protein Expression During Spermatogenesis1

Genyan Yang3,4,5,6, Yong-Lian Zhang6, Gregory M. Buchold4,7, Anton M. Jetten8, and Deborah A. O'Brien2,4,5,7,9

The Laboratories for Reproductive Biology4 Department of Pediatrics,5 University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 State Key Laboratory of Molecular Biology6 , Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Science, Chinese Academy of Sciences, Shanghai, 200031 China Curriculum in Genetics and Molecular Biology,7 University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 Laboratory of Pulmonary Pathobiology,8 Cell Biology Section, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 Department of Cell and Developmental Biology,9 University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Germ cell nuclear factor (GCNF), an orphan receptor in the nuclear receptor superfamily, is expressed predominantly in developing germ cells in the adult mouse. Two Gcnf transcripts (7.4 and 2.1 kilobase [kb]) encoded by a single copy gene are expressed in the testis of several mammalian species. To identify features that regulate Gcnf expression, we characterized the structure and sequence of the mouse gene and its two transcripts and determined the expression profile of the GCNF protein during spermatogenesis. Genomic fragments spanning part of the 5'-untranslated region (UTR), the coding sequence, and the complete 3'-UTR (~80 kb) were isolated and sequenced. The 3'-UTRs of the two transcripts are quite distinct. The 7.4 kb transcript, which appears earlier in spermatogenesis, has a very long 3'-UTR of 4451 nucleotides. In contrast, the 2.1 kb transcript, which is expressed predominantly during the haploid phase of spermatogenesis, has a 3'-UTR that is only 202 nucleotides in length. Additional analyses indicate that both transcripts share the same coding region and are associated with polysomes. A single GCNF protein band was detected in testis extracts by Western blotting with a specific antiserum. Immunohistochemical analysis showed that GCNF is localized in the nuclei of pachytene spermatocytes and round spermatids. GCNF is first detectable in early pachytene spermatocytes (stage II) and is continuously expressed until spermatids begin to elongate in stage IX. Although GCNF is generally distributed throughout the nucleus, it is particularly prominent in heterochromatic regions at some stages and in condensed chromosomes undergoing the meiotic divisions. This expression profile suggests that GCNF plays a role in transcriptional regulation during meiosis and the early haploid phase of spermatogenesis.

GCNF, gene regulation, nuclear orphan receptor, spermatogenesis, testis


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Germ cell nuclear factor (GCNF, NR6A1, RTR) is a novel member of the nuclear receptor superfamily of ligand-activated transcription factors [1, 2]. In mouse and human adult tissues, Gcnf mRNA is expressed at highest levels in the testis [13]. Gcnf transcription is confined to germ cells in both the testis and ovary [1, 2]. In males Gcnf transcription occurs at lower levels during the meiotic prophase in rats and mice [4] and increases substantially in postmeiotic germ cells, with maximum levels in stage VI–VIII round spermatids [4, 5]. In female mice Gcnf mRNA is present in growing oocytes, but it is undetectable in oocytes within primordial follicles [5]. Gcnf is also expressed during embryogenesis, and transcripts are especially abundant in the developing nervous system of mouse and Xenopus embryos [68]. Disruption of Gcnf expression results in embryonic lethality in both species with defects in anteroposterior development, including failures in neural tube closure [9, 10]. In addition to the requirement for Gcnf during embryonic development, Gcnf expression profiles in germ cells suggest that this gene may play critical roles in regulating gene expression during gametogenesis.

An orphan receptor without an identified ligand, GCNF has several distinctive features [11]. It has been classified as the first member of the 6A subfamily of nuclear receptors [12]. Although GCNF has the modular structure characteristic of nuclear receptors, it lacks the conserved transcriptional activation function 2 sequence in the ligand binding domain [13]. GCNF binds as a homodimer to DNA, either to a direct repeat hormone response element without additional nucleotides between the half-sites (DR0) or to extended half-sites [1, 14, 15]. It does not form heterodimers with RXR, a frequent heterodimerization partner of nuclear receptors [13]. In vitro studies suggested that GCNF acts as a transcriptional repressor [6, 16] and may inhibit transcriptional activation mediated by other nuclear receptors [17]. One target of GCNF repression appears to be Oct4, a transcription factor expressed during early germ cell development [18]. Protamine 1 and protamine 2, two genes expressed only during the haploid phase of spermatogenesis, have also been identified as potential targets for GCNF regulation [15, 19].

Another distinctive feature of the Gcnf gene is that two transcripts have been identified that differ in size by ~5 kilobase (kb). Only the larger 7.4 kb Gcnf transcript has been identified in mouse embryos [7], embryonal carcinoma cell lines [20], and in some somatic tissues at significantly lower levels [1, 21]. In contrast, spermatogenic cells express both 7.4 and 2.1 kb Gcnf transcripts [2, 4, 5]. The 7.4 kb transcript is expressed earlier during testicular development and is the predominant Gcnf mRNA in pachytene spermatocytes [4]. The smaller Gcnf transcript is expressed predominantly in haploid round spermatids [4, 5].

Although two Gcnf transcripts have been identified in mouse [1, 2, 4, 5], rat [4, 5], and human testes [3, 21], little is known about the structural or functional differences between these transcripts. The aims of this study were to characterize the structure and sequence of Gcnf and its distinct transcripts and to determine the expression and distribution of the GCNF protein during mouse spermatogenesis. Our detailed analyses provide the first evidence that the majority of the 2.1 and 7.4 kb transcripts share the same coding region, with differences confined to the 5'- and 3'-untranslated regions (UTRs). Polysomal analysis suggests that both Gcnf mRNAs are translated. Consistent with its proposed function as a transcriptional repressor, the GCNF protein is particularly abundant in heterochromatic regions of pachytene spermatocyte and round spermatid nuclei and in condensed chromosomes during the meiotic divisions.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals and Isolation of Spermatogenic Cells

Testes were isolated from CD-1 mice obtained from Charles River Laboratories (Raleigh, NC). All procedures involving animals were approved in advance by the Institutional Animal Care and Use Committee and were conducted in accordance with the National Research Council Guide for Care and Use of Laboratory Animals. Spermatogenic cells were prepared by sequential enzymatic dissociation of adult testes, and pachytene spermatocytes and round spermatids were isolated by unit gravity sedimentation [22]. Purities of pachytene spermatocytes and round spermatids (steps 1–8) exceeded 90%.

Isolation and Sequencing of Gcnf Genomic DNA

Genomic DNA was isolated from mouse liver (129/OlaHsd strain) as previously described [23]. In addition, a P1 plasmid containing Gcnf genomic DNA from the same mouse strain (~150 kb) was obtained from Genome Systems (St. Louis, MO). P1 DNA was prepared according to the instructions provided by the company.

Genomic DNA fragments containing Gcnf coding sequences were generated by subcloning the Gcnf P1 plasmid or by PCR using isolated genomic DNA as a template. Sequences extending beyond the known Gcnf cDNA were generated by genome walking analysis (Clontech, Palo Alto, CA) according to the manufacturer's instructions and confirmed by genomic DNA library screening. DNA sequences were determined using an ABI 3100 sequencer in the DNA Sequencing Facility (University of North Carolina at Chapel Hill) and were assembled and analyzed using the Wisconsin Package Version 10.2, Genetics Computer Group (GCG, Madison, WI). The resulting Gcnf genomic sequences were submitted to the GenBank database (accession numbers AF390897, AF390898, AF390899, AF390900).

Rapid Amplification of cDNA Ends (5'-RACE and 3'-RACE)

5'- and 3'-RACE were carried out using mouse testis Marathon-Ready cDNA (Clontech). Primer sequences were 5'-GAA GGT CAG CAA CGA GGA GTA CG-3' for 3'-RACE and 5'-GTA GTC GTC GTC CTG GTC TTC CAC-3' for 5'-RACE. The 5'-RACE system (version 2.0) from Life Technologies was also used to verify 5'-RACE results. Southern blot analysis was used to confirm that PCR products were derived from Gcnf cDNA. PCR products were excised from agarose gels and purified using Whatman Microspin columns (Whatman, Clifton, NJ). Purified DNA fragments were ligated into the PCRII vector using the TA cloning system (Invitrogen, Carlsbad, CA) and were transformed in E. coli XL1-Blue competent cells using standard molecular biological techniques. The clones were sequenced in the DNA Sequencing Facility (University of North Carolina at Chapel Hill). The derived Gcnf cDNA sequence was submitted to the GenBank database (accession number AF390896).

Genomic Library Screening

A 129 SVJ mouse genomic library in Lambda FIX II (Stratagene, La Jolla, CA) was screened as previously described [24]. Briefly, the library was plated, transferred to nylon filters, and screened using a 405 base pair (bp) probe located before the DNA-binding domain (DBD) of mouse Gcnf (nt 112–525 of AF390896). Positive clones from the first screening of 1 x 106 plaques were plated and subjected to second screening using the same probe. Candidate clones were plaque-purified and confirmed by Southern blotting using a second Gcnf probe (nt 735–1084 of AF390897).

Southern Blot Analysis

Genomic (10 µg/lane) and P1 plasmid DNA (300 ng/lane) were digested with restriction endonucleases (BamHI, HindIII, XbaI, KpnI, and NcoI, Life Technologies, Rockville, MD), and fragments were separated on 0.7% agarose gels. The separated DNA fragments were transferred to Hybond N+ nylon membranes (Amersham Pharmacia Biotech, Piscataway, NJ) using the downward alkaline capillary transfer method [25]. Blots were hybridized with a 238 bp [32P]-labeled probe generated from the Gcnf ligand-binding domain (nt 1001–1238 of AF390896) using ULTRAhyb (Ambion, Austin, TX) according to the manufacturer's instructions. Washed blots were exposed to x-ray film or to a PhosphorImager screen followed by analysis with a STORM869 PhosphorImager (Molecular Dynamics, Sunnyville, CA).

RNA Isolation and Northern Blot Analysis

Total RNA was isolated from mouse testis, pachytene spermatocytes, or round spermatids using the acid-phenol guanidine isothiocyanate method [26]. RNA samples were denatured, electrophoresed on 1.2% formamide agarose gels, and transferred to Hybond-N+ nylon membranes (Amersham Pharmacia Biotech). Transcript sizes were determined by comparisons with markers designed for accurate RNA size determination on Northern blots (Millennium Markers, Ambion). RNA was fixed to the membrane using a Stratalinker UV cross-linker (Stratagene). Blots were hybridized with radioactive probes at 65°C in Church buffer as described previously [27]. In some experiments ULTRAhyb (Ambion) was used for hybridizations according to the manufacturer's instructions. Blots were exposed either to x-ray film at -70°C or to a PhosphorImager screen for analysis with a STORM869 PhosphorImager (Molecular Dynamics).

Specific Amplification of Each Gcnf Transcript

Total RNA (3.0 µg) isolated from testes of adult CD-1 mice was used for reverse transcription (RT) using the ThermoScript RT-PCR System according to the manufacturer's instructions (Life Technologies). Primer L was generated from the 3'-UTR region that is specific to the 7.4 kb Gcnf transcript (nt 2770–2794 of AF390896) and was used for RT. The derived cDNA was used for PCR reactions with primer L and a forward primer generated from the first exon (nt 121–146 of AF390896). A primer specific for the 2.1 kb Gcnf (GSP-T18) was generated to anneal to the last eight nucleotides of the 3'-UTR and the initial segment of the poly (A) tail (illustrated in Fig. 5). Following RT with this primer, PCR amplification was performed with the same forward primer used to amplify sequences from the 7.4 kb transcript and a reverse primer derived from exon 10 (nt 1744–1772 of AF390896). The cDNA products from each RT-PCR reaction were cloned into the TA vector (Invitrogen) for sequence analysis.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 5. Specific amplification of the 2.1 kb Gcnf transcript by reverse transcription-polymerase chain reaction (RT-PCR). A) Diagram of the primers used for reverse transcription. The 3' ends of both Gcnf mRNAs are indicated. Primer L is unique to the 7.4 kb mRNA, and primer GSP-T18 was designed to anneal efficiently only with the 2.1 kb mRNA due to its poly (A) tail. The GSP primer with six nucleotides common to both transcripts was used as a negative RT-PCR control. B) and C) Separation of RT-PCR products on agarose gels. Total RNA (3.0 µg) from adult mouse testis was used for the RT reaction. PCR was performed using a forward primer generated from the first exon beyond the coding region and a reverse primer from a region in exon 11 that is common to both transcripts. DNA size markers were loaded in lane 1 (B and C). A 2.6 kb product was generated using primer L (B, lane 2). The GSP-T18 product was 1.6 kb in length (C, lane 2), whereas no product was obtained with the control GSP primer (C, lane 3)

Polysome Analysis

Polysome gradients were performed as described previously [2830]. Briefly, isolated spermatogenic cells (3.7 x 107 pachytene spermatocytes, 1.7 x 108 round spermatids) were homogenized with a Dounce homogenizer on ice in 1.0 ml lysis buffer (100 mM NaCl, 1.5 mM MgCl2, and 20 mM Hepes, pH 7.6). The nuclei and mitochondria were pelleted by centrifugation for 5 min at 12 000 x g. Supernatants were loaded onto linear gradients of 15%–50% sucrose (w/w) in lysis buffer over a 0.5-ml 70% sucrose cushion, and were centrifuged for 3 h at 39 000 rpm in a Beckman SW-40 rotor. The gradients were fractionated into ten 1.2-ml fractions, and the RNA in each fraction was precipitated with 0.3 M sodium acetate and isopropanol. RNAs were dissolved in DEPC-treated water, purified with the RNeasy mini kit (Qiagen, Valencia, CA) and subjected to Northern blot analysis (20% of the RNA isolated from each fraction). Control gradients, with 20 mM EDTA replacing MgCl2 in the buffer, were centrifuged and analyzed in parallel to the polysome gradients using 2% of the total RNA isolated from each fraction. After hybridization with radioactive probes specific for Gcnf (nt 1001–1238 of AF390896) or phosphoglycerate kinase-2 (Pgk2, nt 1010–1350 of NM_031190), Northern blots were exposed to Kodak BioMax MS (for pachytene spermatocytes) or X-Omat AR x-ray films (for round spermatids) at -70°C overnight. The Pgk2 probe binds to a Pgk2 region that shares 82% identity with the Pgk1 mRNA, suggesting that this probe may recognize transcripts for both isozymes.

Western Blot Analysis

Testes from adult mice were decapsulated and homogenized in lysis buffer (2% SDS, 100 mM DTT, 60 mM Tris pH 6.8, 10% glycerol). Samples were denatured for 10 min at 85°C, centrifuged at 10 000 x g for 10 min, and protein concentrations were determined with the bicinchoninic acid assay (Pierce Chemical Company, Rockford, IL). Testis proteins (30–50 µg/lane) and molecular weight markers (BenchMark Protein Ladder, Life Technologies) were separated on 10% SDS-polyacrylamide gels and transferred to PVDF membranes (Millipore Corporation, Bedford, MA) for 90 min at 100 mA using a semidry blotter.

Western blot analysis was performed with an antiserum raised against a unique peptide sequence in GCNF (DSDHSSPGNRASESNQPSC). Previous studies demonstrated that this antiserum specifically immunoprecipitates GCNF and causes a supershift of GCNF-nucleotide complexes in electrophoretic mobility shift assays [15]. Blots were blocked with 5% nonfat dry milk and incubated with this GCNF antiserum (diluted 1:1200) followed by an affinity-purified secondary antibody conjugated to horseradish peroxidase (1:30 000, goat anti-rabbit IgG; Kierkegaard and Perry Laboratories, Gaitherburg, MD). Control blots were incubated under identical conditions, except that the primary antibody was preincubated with the GCNF peptide (60 µg/ml) used to raise this antiserum. The blots were washed after each incubation and immunoreactivity was detected with a chemiluminescent substrate for peroxidase (SuperSignal West Pico substrate, Pierce, Rockford, IL).

Immunohistochemistry

GCNF was localized on paraffin sections of Bouin fixed mouse testes using the avidin-biotin immunoperoxidase method (Vectastain ABC kit; Vector Laboratories, Burlingame, CA) as described previously [31]. Prior to immunostaining, the sections were immersed in 1.0 mM EDTA in phosphate-buffered saline (pH 8.0) and microwaved (750 W, three 5 min cycles) for antigen retrieval [32]. The same GCNF antibody used for Western blots was used at concentrations of 1:3000 to 1:4000 for immunohistochemistry. For control sections, the GCNF antiserum was preincubated with the immunogenic peptide (60 µg/ml). Immune complexes were detected using 3'3'-diaminobenzidine tetrahydrochloride (Aldrich Chemical Company, Milwaukee, WI) as the chromogen. Slides were counterstained with Gill hematoxylin (Fisher Scientific, Pittsburgh, PA) and photographed using a Spot RT Slider digital camera (Diagnostic Instruments, Sterling Heights, MD).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
One Gene Encodes Both Gcnf Transcripts

Gcnf encodes two transcripts that differ in length by more than 5 kb. The initial report that Gcnf is a single-copy gene [1] was based on Southern blot analysis using a probe that spanned the cloned 3'-UTR, apparently including an extensive region that is unique to the large transcript [4]. To determine if both Gcnf mRNAs are encoded by one gene, we digested genomic DNA with five restriction endonucleases and performed Southern blot analysis using probes common to both transcripts. A 238-bp probe derived from the ligand-binding domain (nt 1001–1238 of AF390896) hybridized to a single DNA fragment in each lane of the Southern blots (Fig. 1, A and B). This probe also hybridized to both 2.1 and 7.4 kb Gcnf transcripts on Northern blots (Fig. 1C). Since sequence data was derived from both P1 plasmid DNA containing Gcnf genomic sequence and from mouse liver DNA, we confirmed that the restriction patterns were identical for both sources of Gcnf genomic DNA (compare Fig. 1, A and B). We also probed Southern blots with three other probes to distinct regions within the open reading frame and obtained similar results (data not shown). These results demonstrate that both Gcnf transcripts are encoded by a single copy gene.



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 1. Southern blot analysis of Gcnf. P1 plasmid DNA containing Gcnf (A, 300 ng/lane) and mouse liver genomic DNA (B, 10 µg/lane) were digested with restriction endonucleases BamHI (1), HindIII (2), XbaI (3), KpnI (4), or NcoI (5), electrophoresed on agarose gels, and transferred to nylon membranes. The Southern blots (A and B) were hybridized with a probe that binds to a segment in the Gcnf coding region. This probe binds to a region that is common to the 7.4 and 2.1 kb Gcnf transcripts, as demonstrated by Northern blot analysis (C) of total RNA (10 µg/lane) from mouse testis (T) and round spermatids (R)

Genomic Structure of Gcnf

We have sequenced ~80 kb of Gcnf genomic DNA, spanning part of the 5'-UTR, the entire open reading frame, and the complete 3'-UTRs for both Gcnf transcripts (GenBank AF390897AF390900). The Gcnf coding region contains 11 exons and 10 introns (Fig. 2). Intron-exon boundaries, with typical splice donor and acceptor sites, were determined by comparing genomic DNA and cDNA sequences (Table 1). Nine of the introns range in size from 1.0 to 15.9 kb, and the tenth has a minimum size of 12 kb. The complete DNA sequence was determined for seven of the introns. The exon that encodes the first 33 amino acids of GCNF was designated exon 1. An additional exon upstream of exon 1 (asterisk in Fig. 2) was identified by RT-PCR, although we were unable to confirm this sequence by Northern blot analysis.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 2. Diagram correlating mouse Gcnf with the two mRNAs (2.1 and 7.4 kb) and protein encoded by this gene. The Gcnf gene diagram shows the relative lengths of exons 1–11 and intervening introns. An additional exon (asterisk) was identified by RT-PCR. Line breaks in the gene diagram indicate that four of the introns have lengths >8 kb and are not drawn to scale. The Gcnf mRNAs are shown, indicating that the two transcripts share the same open reading frame (wider open box). Narrower segments represent the 5'- and 3'-untranslated regions. Regions of the 2.1 and 7.4 kb mRNAs encoded by exon 11 are designated 11S and 11L, respectively. A break in 11L indicates that this 4.4 kb 3'-untranslated region is not drawn to scale. The GCNF protein diagram denotes amino acids corresponding to each exon and functional domains, as described previously [11, 33], including the N-terminal domain (NTD); the DNA-binding domain (DBD, C75-M140); two motifs referred to as T-box and A-box (T/A-box); the hinge region (HR); and the ligand binding domain (LBD).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Exon-intron boundaries in mouse Gcnf gene

The complete DBD of GCNF is encoded by exon 4 (242 bp, Fig. 2). Unlike most members of the nuclear receptor superfamily, the Gcnf gene has no introns separating the two zinc fingers in the DBD region. Exons surrounding the DBD are quite small, including exons 2 and 3 (42 and 45 bp) and exon 5 (56 bp). Exon 5 encodes the T/A-box domain, a highly conserved 18-amino acid region that mediates specific DNA binding and receptor dimerization [11, 33]. Exons 2–5 are separated by three large introns (>12, 15.9, and 13.5 kb; Fig. 2 and Table 1). The hinge region of GCNF, reported to be essential for interaction with the nuclear corepressor N-CoR [17], is encoded by exon 6 and part of exon 7. Exons 8–11 encode the ligand-binding domain, a region capable of adopting different conformations with distinct dimerization, DNA-binding, and transcriptional properties [33].

Complete Sequence of the 3'-UTRs for Both Gcnf Transcripts

Exon 11 encodes the 3'-UTR regions of both Gcnf mRNAs (Fig. 2 and Table 1). We used 3'-RACE to determine the full length of the 3'-UTR for each transcript. Initially, we obtained two cDNA clones with poly (A) tails at their 3' ends. Both clones hybridized to Gcnf mRNAs on Northern blots. Comparisons of Gcnf cDNA and genomic DNA sequences indicated that one of the clones resulted from annealing of the poly (T) primer to an internal poly (A) sequence in the 3'-UTR of the 7.4 kb transcript (bold type in Fig. 3). Therefore, another primer downstream of this internal sequence was generated to complete 3'-RACE and comparative sequence analysis of the larger transcript.



View larger version (49K):
[in this window]
[in a new window]
 
FIG. 3. Sequence features of the 3'-untranslated regions of Gcnf mRNAs. Partial sequences of the Gcnf 3'-untranslated regions (UTRs) are shown, beginning with the stop codon (bold TGA). Breaks in the sequence are indicated on the right (·····). The arrow after nucleotide 2078 (A) denotes the end of the 2.1 kb mRNA. The AAUAAA polyadenylation signal for the 7.4 kb transcript is highlighted by a shaded rectangle (nt 6302–6307). 3'-RACE detected initiation of the poly (A) tail at nucleotide 6321 (C) or nucleotide 6327 (T) for the larger transcript. An internal poly (A) sequence in the 7.4 kb transcript is highlighted by bold type. Potential regulatory elements in the 3'-UTR of the larger transcript include five differential control elements (DICE, underlined and italicized sequences) and an iron-response element (IRE, double underline). For complete sequence, see GenBank AF390896

The 3'-UTR of the 7.4 kb transcript is 4451 nucleotides in length, much longer than the average length of 600 nucleotides reported for terminal exons of vertebrate genes [34]. Selected regions of the 3'-UTR sequence are shown in Fig. 3. A conserved polyadenylation signal (AAUAAA) was identified near the end of the 7.4 kb transcript, and polyadenylation appeared to be initiated in two positions. The 3'-UTR sequence of the larger Gcnf transcript was analyzed with UTRscan, a program that searches for UTR functional elements that may regulate mRNA localization, stability, or translational efficiency [35]. This program identified five regions (underlined in Fig. 3) with sequence similarity to tandem repeats referred to as differential control elements. The binding of regulatory proteins to these elements inhibits the translation of erythroid 15-lipoxygenase mRNA [36, 37]. A putative iron-response element was also identified just before the poly (A) tail (double underline in Fig. 3). Iron-response elements located within the 3'-UTR of transferrin receptor mRNA have been implicated in iron-dependent regulation of mRNA stability [38].

The 3'-UTR of the 2.1 kb Gcnf transcript is 202 nucleotides in length, as determined by 3'-RACE (complete sequence shown in Fig. 3). The UTR scan program did not identify any common motifs in this shorter 3'-UTR. Like many other mRNAs expressed in male germ cells, the 2.1 kb transcript does not have a typical polyadenylation signal near the poly (A) tail [39, 40]. Northern blot analysis was used to confirm the 3' end of the 2.1 kb transcript. A probe derived from a common region of the Gcnf sequence (probe 1 in Fig. 4) detected both transcripts, whereas a probe specific for the 7.4 kb mRNA ([4]; probe 3 in Fig. 4) detected only the larger transcript. Probe 2 was designed to hybridize to the region immediately after the predicted 3' end of the 2.1 kb transcript. As predicted by 3'-RACE, this probe detected only the larger 7.4 kb transcript (Fig. 4).



View larger version (46K):
[in this window]
[in a new window]
 
FIG. 4. The 3' end of the 2.1 kb Gcnf transcript. Northern blot analysis was performed to confirm the 3' end of the 2.1 kb mRNA. A) Schematic description of probes used for the analysis. The nucleotide positions of three probes and the ends of the transcripts derived by 3'-RACE are indicated, according to GenBank sequence AF390896. Probe 1 is in a region common to the two Gcnf transcripts, probe 2 binds to a sequence just after the predicted 3' end of the small transcript, and probe 3 is in a region unique to the large transcript. B) Total RNA (10 µg/lane) from testes of adult mice was used for Northern blot analysis. The probe used for hybridization is indicated above each lane, and transcript sizes are shown on the right

Both Gcnf Transcripts Share the Same Coding Region

In our previous Northern analyses, cDNA probes derived from two distinct regions in the open reading frame hybridized to both Gcnf transcripts [4]. These results confirmed that some sequences in the two transcripts are shared, but did not rule out alternative splicing within the coding region. Using exon-specific probes on Northern blots of testicular RNA, we determined that both the 7.4 and 2.1 kb transcripts include sequences encoded by exon 1 and exons 4–11 (data not shown). However, Northern probes specific for exons 2 and 3 were not practical because of the small size of these exons.

To confirm the Northern results and determine if both Gcnf transcripts include sequences from exons 2 and 3, we performed RT-PCR with primers specific for each transcript. The primer sequence specific for the 7.4 kb mRNA (L in Fig. 5A) was derived from the unique 3'-UTR of this transcript (nt 2635–2789 of AF390896). We designed a primer specific for the 2.1 kb transcript based on our 3'-RACE results, since Gcnf sequences restricted to this transcript have not been identified. This primer (GSP-T18; Fig. 5A) anneals to a region including the last eight nucleotides of the 3'-UTR and 18 adenine nucleotides in the poly (A) tail. Reverse transcription was performed with these transcript-specific primers and the cDNAs were amplified by PCR. The resulting RT-PCR products were 2.6 kb in length for the large transcript (Fig. 5B) and 1.6 kb for the small transcript (Fig. 5C), matching the sizes expected from the cDNA without alternative splicing within the coding region. The same RT-PCR conditions used for the GSP-T18 primer were used for RT-PCR with a control primer lacking the poly (T) tail (GSP, Fig. 5A). No products were amplified with the GSP primer (Fig. 5C, lane 3), ruling out the possibility that the 1.6 kb product resulted from reverse transcription of the large Gcnf transcript.

Several independent cDNA clones generated by RT-PCR were sequenced, including 20 clones from each of the transcript-specific reactions and 10 from a reaction with a common primer. Nineteen clones derived from the 7.4 kb mRNA had identical sequences, including all intervening exons. One clone did not contain a sequence from exon 3 (M2 in Fig. 6). Nineteen clones derived from the 2.1 kb transcript also had identical sequences with all exons included. One clone had a short deletion corresponding to the beginning of exon 4 (M3 in Fig. 6). Exons 2 and 3 were deleted in clone M1, derived from RT-PCR with a primer common to both transcripts. However, nine other clones had identical sequences with no deletions. Thus RT-PCR and sequence analysis indicate that Gcnf transcripts in mouse testis share the same open reading frame, but alternative splicing may occur in a small portion of transcripts.



View larger version (19K):
[in this window]
[in a new window]
 
FIG. 6. Alignment of mouse and human GCNF amino acid sequences before the DNA binding domain. Partial amino acid sequences for the region preceding the DNA binding domain are indicated in bold type for mouse (mGCNF) and human (hGCNF) GCNF. Arrows indicate corresponding intron positions from the mouse genomic sequence. Fifty mouse cDNA clones generated by RT-PCR were sequenced, and three clones had deletions in this region (M1, M2, M3). The M1 clone was derived using primers common to both Gcnf transcripts (one out of 10 clones). M2 and M3 were generated using primers unique to 7.4 kb and 2.1 mRNAs, respectively (deletions found in one out of 20 clones from each reaction). Similar deletions have been reported for human GCNF and are shown for comparison (H1, H2). Two casein kinase II phosphorylation sites in the deleted region are underlined. References for published sequences are shown on the right

Both Gcnf mRNAs Are Translated During Spermatogenesis

We used sucrose gradient sedimentation analysis to determine if both Gcnf transcripts are bound to polysomes in pachytene spermatocytes and round spermatids (Fig. 7). Using a Pgk probe to calibrate the gradients by Northern blot analysis, we detected mRNAs in both the polysomal (fractions 7–10) and nonpolysomal (fractions 1–4) regions of the gradient for each cell type (lower panels, Fig. 7). In the presence of EDTA, these mRNAs dissociate from ribosomes and sediment more slowly than when bound to polysomes. The fractionation of 7.4 kb and 2.1 kb Gcnf mRNAs was monitored with a probe common to both transcripts (upper panels, Fig. 7). Similar to Pgk transcripts, the Gcnf transcripts are localized predominantly in the nonpolysomal fractions in the upper half of each gradient. However, a portion of the 7.4 kb mRNAs sediment in the polysomal regions of the gradient in both pachytene spermatocytes and round spermatids. The 2.1 kb Gcnf mRNA, which is predominantly expressed in round spermatids, is also present in the polysomal fractions. Both 7.4 and 2.1 kb transcripts are dissociated from polysomes in the presence of EDTA and migrate near the top of each gradient. In addition, EDTA reduced the rate of sedimentation of the major peak of Gcnf mRNA from fractions 4 and 5 (gradients containing MgCl2) to fractions 2 and 3.



View larger version (80K):
[in this window]
[in a new window]
 
FIG. 7. Distribution of Gcnf transcripts in polysomal gradient fractions from pachytene spermatocyte and round spermatid extracts. Cytoplasmic extracts were prepared in lysis buffer with MgCl2 (experimental samples) or EDTA (control) and sedimented on 15%–50% sucrose (w/w) gradients over a 70% sucrose cushion. Ten fractions were collected from each gradient and were numbered from the top of the gradient (1) to the bottom (10). Total RNA was isolated from each fraction. Northern blot analysis was performed using a Gcnf probe common to both 7.4 and 2.1 kb transcripts (upper panels). The blots were stripped and then hybridized with a control Pgk probe (lower panels). Northern blots from pachytene spermatocyte extracts are shown on the left, and blots from round spermatid extracts are shown on the right

Localization of the GCNF Protein During Spermatogenesis

A GCNF-specific antiserum [15] was used to analyze the expression of this protein in mouse testis. Western blot analysis confirmed the specificity of this antiserum. We detected a single band of the appropriate size (predicted GCNF molecular weight = 55 975) on blots of testicular proteins (Fig. 8, lane 1). Immunoreactivity was blocked completely when the antiserum was preincubated with the peptide immunogen (Fig. 8, lane 2).



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 8. Western immunoblot analysis of GCNF. Testis lysates (50.0 µg/lane) from adult mice were separated on 10% SDS-polyacrylamide gels and transferred to PVDF membranes. A GCNF antiserum (1:1200 dilution) raised against a peptide sequence encoded by both GCNF transcripts recognized a single band (lane 1) in the testis lysates. Immunoreactivity was completely blocked by preincubation of the antiserum with the immunogenic peptide (60.0 µg/ml, lane 2)

Sections of adult mouse testis were immunostained with the same antiserum to assess the temporal appearance of GCNF during spermatogenesis and determine its subcellular localization (Fig. 9). The GCNF protein was detected in every tubule cross section (Fig. 9A), primarily in the nuclei of pachytene spermatocytes (p) and round spermatids (r). Less prominent staining in the acrosomes of elongating spermatids (e) and in interstitial tissue between tubules (i) appeared to be nonspecific, since this staining could not be blocked by preincubation of the antiserum with the peptide immunogen (Fig. 9B).



View larger version (144K):
[in this window]
[in a new window]
 
FIG. 9. GCNF protein expression during spermatogenesis. The same GCNF antiserum used for Western analysis (Fig. 8) was used for immunohistochemistry on adult mouse testis sections (A, CJ). GCNF was localized in the nuclei of pachytene spermatocytes (p) and round spermatids (r) throughout the testis (A). Most of the immunoreactivity was eliminated by preincubation of the antiserum with 60 µg/ml immunogenic peptide (B), except for faint nonspecific staining in interstitial cells (i) and the acrosomes of elongating spermatids (e). Higher magnification micrographs show stage-specific changes in GCNF expression (CJ). GCNF was first detected in a spherical nuclear structure in stage II–IV pachytene spermatocytes (arrows in D and E). GCNF immunoreactivity increased throughout the remaining pachytene stages (p in FI) and remained prominent during the meiotic divisions (J) and in stage I–V round spermatids (r in CF). Nuclear immunostaining was less intense in stage VII and VIII round spermatids (r in G and H) and barely detectable in elongating spermatids (e in I). GCNF was not detected in spermatogonia (g in F), early spermatocytes (c in GI), or Sertoli cells (s in C and F). Magnification x150 in A and B; x600 in C–J

As germ cells differentiate, they move from the basal lamina to the lumen of the seminiferous tubule where spermatozoa are released. Because spermatogenesis proceeds with precise kinetics, each cross section of a seminiferous tubule has a distinct cellular association with multiple layers of germ cells developing synchronously. Twelve cellular associations or stages have been identified in the mouse [41]. To examine the relative distribution of GCNF during the meiotic and postmeiotic phases of spermatogenesis, we compared successive stages in the same testis section (Fig. 9, C–J). GCNF immunostaining was not observed in cells closest to the basal lamina, including spermatogonia (g, Fig. 9F); early spermatocytes (c, Fig. 9, G–I); and supporting Sertoli cells (s, Fig. 9, C and F). GCNF was first detected during the pachytene phase of meiosis. Although early pachytene spermatocytes (p) in stage I were unstained (Fig. 9C), GCNF appeared in stage II–IV pachytene spermatocytes within a spherical structure in the nucleus (arrows in Fig. 9, D and E). It is likely that this structure is the XY body, a subregion occupied by the condensed X and Y chromosomes, previously reported to be the only site of GCNF immunostaining in mouse testes [42]. GCNF immunostaining increased during subsequent stages of pachytene spermatocyte differentiation (p in stages V–X, Fig. 9, F–I). During the meiotic divisions in stage XII, condensed chromosomes were intensely labeled with the GCNF antiserum.

The haploid period of differentiation follows the meiotic divisions, beginning with round spermatids in stage I (r, Fig. 9C). GCNF is abundant in round spermatid nuclei (stages I–VIII), particularly in stages I–V (Fig. 9, C–H). Immunostaining is particularly prominent in the heterochromatic region in the center of round spermatids (arrows in Fig. 9, G and H) [43]. As the spermatids begin to elongate in stages IX and X, nuclear GCNF is markedly reduced (e in Fig. 9I).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In order to broaden our understanding of features that modulate GCNF expression, we characterized the genomic structure of the mouse Gcnf gene. Our studies provide conclusive evidence that this single-copy gene encodes two mRNAs (7.4 and 2.1 kb) that differ in both the 5'- and 3'-UTRs. In addition to confirming exon-intron boundaries reported previously [44, 45], we determined intron sizes and a more extensive Gcnf sequence including extended 5'- and 3'-UTR sequences and the complete sequence of seven introns. Our results do not support the published sequence of exon 1 [44, 45]. We obtained a similar cDNA by 5'-RACE, which had a sequence that matched the preceding intron. However, this cDNA probe recognized a single 1.5 kb band on Northern blots, indicating that it was not part of the Gcnf DNA sequence (data not shown). We also obtained four other divergent cDNA clones by 5'-RACE with regions that were highly homologous to the N-terminal domain of Gcnf, suggesting that GCNF may be structurally and perhaps functionally related to the other proteins. Our 5'-RACE analyses identified an additional exon preceding exon 1 (indicated by the asterisk in Fig. 2 and Table 1) that was verified as a Gcnf sequence by RT-PCR. However, we were unable to detect this sequence on Northern blots, suggesting that alternative splicing may occur in this region and that this exon may be included in a small portion of Gcnf transcripts.

Using 3'-RACE, we determined the complete sequence of the 3'-UTRs for both Gcnf transcripts. Our results extend the known cDNA sequences for the 2.1 and 7.4 kb transcripts to 1975 and 6137 nucleotides, respectively (see GenBank AF390896). Although the smaller transcript was originally estimated to be 2.3–2.4 kb [1, 2], we have revised the estimated length to 2.1 kb after careful comparisons with markers designed for accurate RNA size determination on Northern blots (Millennium Markers, Ambion). Therefore, we may have obtained the full length cDNA for the small transcript, since several transcripts in round spermatids have poly (A) tracts of ~150 bases [46]. However, we were unable to determine the transcription start site of the 2.1 kb mRNA by primer extension assays, despite many attempts. It is likely that these experiments were hampered by the very high GC content (74%) of exon 1, which includes 286 bp of the 5'-UTR. In fact, none of the published mouse and human Gcnf cDNAs include sequences preceding this GC-rich region [13, 13, 21, 47, 48]. Consequently, the sequence of the 5' end of the 7.4 kb Gcnf transcript that precedes this region (~1.2 kb) remains unknown.

Exons 2 and 3 of Gcnf, which immediately precede the DNA binding domain, are small exons (42 and 45 bp) surrounded by large introns (8.5, >12, and 15.9 kb). Published human GCNF cDNA clones do not contain sequences corresponding to exon 3 in mouse Gcnf [3, 13, 21, 47, 48]. Furthermore, splice variants for human GCNF have been reported with multiple deletions in the N-terminal domain (1; see Fig. 6). To determine if similar alternative splicing occurs in the mouse, we designed primers specific for each of the Gcnf transcripts and analyzed the sequences of RT-PCR-generated clones. These results provide the first evidence that the majority of the 2.1 and 7.4 kb transcripts expressed in mouse testis share the same coding region. Although we did detect small deletions in the region preceding the DNA binding domain (exon 2 through the beginning of exon 4), these deletions occurred in only 6% of the sequenced RT-PCR clones (3/50). Structural elements such as suboptimal splicing signals may account for the observed clustering of Gcnf deletions in this region [49]. For example, truncation of the 5' end of exon 4 (M3 in Fig. 6) may have resulted from the use of a cryptic splice acceptor site, since the deleted fragment (TTTCCGTCCCAG) is very similar to the consensus 3' splice site (polypyrimidine NCAG) [50].

Translational repression is a common feature of gene expression during meiosis and haploid differentiation of spermatids [51], the two phases of spermatogenesis where Gcnf is transcribed [4]. Furthermore, we identified potential regulatory elements in the long 3'-UTR of the 7.4 kb transcript that may contribute to reduced translation or mRNA stability. To determine if both Gcnf transcripts are associated with polysomes, we analyzed cell lysates on sucrose gradients. As reported for the majority of mRNAs in pachytene spermatocytes and round spermatids [51], significant fractions of the 2.1 and 7.4 kb transcripts were found in nonpolysomal fractions of both cell types. However, a portion of both Gcnf transcripts were associated with polysomes, suggesting that both are translated during spermatogenesis. In addition, the observed effect of EDTA on the slowly sedimenting major peak of Gcnf transcripts suggests that unusual features of these mRNAs such as upstream reading frames may promote association with monosomes and small polysomes [46].

A previous study using a different antibody detected GCNF protein in isolated mouse pachytene spermatocytes and round spermatids on Western blots, but only in the XY body of pachytene spermatocyte nuclei in immunofluorescence assays [42]. In our studies GCNF was distributed throughout the nucleus of both pachytene spermatocytes and round spermatids. GCNF was first detected in stage II–IV pachytene spermatocytes in a nuclear structure consistent with the XY body, which contains the condensed X and Y chromosomes. We also observed high levels of GCNF in condensed chromosomes undergoing the meiotic divisions and in the central heterochromatic region in round spermatid nuclei. The prominence of GCNF in heterochromatic regions and meiotic chromosomes is consistent with reports that this orphan receptor functions as a transcriptional repressor [6, 16, 17, 33].

Protamine 1 and protamine 2, which have DR0 response elements in their promoters, have been identified as potential targets for GCNF regulation [15, 19]. The mRNAs for these sperm nuclear proteins are transcribed in round spermatids [52], but are not translated until step 11–12 spermatids [53, 54]. Since GCNF levels are high when protamine mRNAs begin to accumulate in round spermatids, it seems unlikely that GCNF inhibits the transcription of the protamines during these stages. However, interactions of GCNF with other proteins or cross-talk between nuclear receptor signaling pathways [17] could modulate the expression of the protamine genes during spermatogenesis.

In summary, this study provides additional information on potential regulatory regions of Gcnf including quite diverse 3'-UTR sequences for the two transcripts, confirms that the same protein is translated from both transcripts, and defines the stages of spermatogenesis where the GCNF protein is expressed. These results suggest that GCNF plays a transcriptional regulatory role during spermatogenesis, from the pachytene stage of meiotic prophase through the early phase of spermatid differentiation. Additional studies are needed to identify other genes that are potential GCNF targets during these stages and to define mechanisms that regulate the transcription and translation of the two Gcnf mRNAs during spermatogenesis.


    ACKNOWLEDGMENTS
 
We thank Patricia L. Magyar for expert technical assistance with immunohistochemistry; Dr. James K. Tsuruta, Dr. David Fenstermacher, and Dr. Wayne Litaker for helpful discussions; and members of the O'Brien and Zhang laboratories for excellent cooperation and encouragement. We extend special thanks to Dr. E.M. Eddy and Dr. Masuo Goto (NIEHS, NIH) for assistance with genomic library screening and polysomal analysis.


    FOOTNOTES
 
1 Supported by NIH grants TW/HD00627, CA16086 (UNC Lineberger Comprehensive Cancer Center), and cooperative agreement U54 HD35041 as part of the Specialized Cooperative Centers Program in Reproductive Research. Funding was also provided by the Chinese National Natural Sciences Foundation 39893320 and the Chinese 95 Yu-Pan-deng Plan funding project 1997-066. Back

2 Correspondence: Deborah A. O'Brien, Department of Cell and Developmental Biology, CB# 7090, 214A Taylor Hall, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7090. FAX: 919 966 1856; dao{at}med.unc.edu Back

3 Current address: Vanderbilt-Ingram Cancer Center, 512 Preston Research Building, Vanderbilt University, Nashville, TN 37232-6838 Back

Received: 9 October 2002.

First decision: 31 October 2002.

Accepted: 21 November 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Chen F, Cooney AJ, Wang Y, Law SW, O'Malley BW. Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. Mol Endocrinol 1994 8:1434-1444[Abstract]
  2. Hirose T, O'Brien DA, Jetten AM. RTR: a new member of the nuclear receptor superfamily that is highly expressed in murine testis. Gene 1995 152:247-251[CrossRef][Medline]
  3. Süsens U, Borgmeyer U. Characterization of the human germ cell nuclear factor gene. Biochim Biophys Acta 1996 1309:179-182[Medline]
  4. Zhang YL, Akmal KM, Tsuruta JK, Shang Q, Hirose T, Jetten AM, Kim KH, O'Brien DA. Expression of germ cell nuclear factor (GCNF/RTR) during spermatogenesis. Mol Reprod Dev 1998 50:93-102[CrossRef][Medline]
  5. Katz D, Niederberger C, Slaughter GR, Cooney AJ. Characterization of germ cell-specific expression of the orphan nuclear receptor, germ cell nuclear factor. Endocrinology 1997 138:4364-4372[Abstract/Free Full Text]
  6. Bauer UM, Schneider-Hirsch S, Reinhardt S, Pauly T, Maus A, Wang F, Heiermann R, Rentrop M, Maelicke A. Neuronal cell nuclear factor—a nuclear receptor possibly involved in the control of neurogenesis and neuronal differentiation. Eur J Biochem 1997 249:826-837[Medline]
  7. Süsens U, Aguiluz JB, Evans RM, Borgmeyer U. The germ cell nuclear factor mGCNF is expressed in the developing nervous system. Dev Neurosci 1997 19:410-420[Medline]
  8. Joos TO, David R, Dreyer C. xGCNF, a nuclear orphan receptor is expressed during neurulation in Xenopus laevis. Mech Dev 1996 60:45-57[CrossRef][Medline]
  9. Chung AC, Katz D, Pereira FA, Jackson KJ, DeMayo FJ, Cooney AJ, O'Malley BW. Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior truncation. Mol Cell Biol 2001 21:663-677[Abstract/Free Full Text]
  10. David R, Joos TO, Dreyer C. Anteroposterior patterning and organogenesis of Xenopus laevis require a correct dose of germ cell nuclear factor (xGCNF). Mech Dev 1998 79:137-152[CrossRef][Medline]
  11. Greschik H, Schüle R. Germ cell nuclear factor: an orphan receptor with unexpected properties. J Mol Med 1998 76:800-810[CrossRef][Medline]
  12. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999 97:161-163[CrossRef][Medline]
  13. Kapelle M, Krätzschmar J, Husemann M, Schleuning WD. cDNA cloning of two closely related forms of human germ cell nuclear factor (GCNF). Biochim Biophys Acta 1997 1352:13-17[Medline]
  14. Borgmeyer U. Dimeric binding of the mouse germ cell nuclear factor. Eur J Biochem 1997 244:120-127[Medline]
  15. Yan ZH, Medvedev A, Hirose T, Gotoh H, Jetten AM. Characterization of the response element and DNA binding properties of the nuclear orphan receptor germ cell nuclear factor/retinoid receptor-related testis-associated receptor. J Biol Chem 1997 272:10565-10572[Abstract/Free Full Text]
  16. Cooney AJ, Hummelke GC, Herman T, Chen F, Jackson KJ. Germ cell nuclear factor is a response element-specific repressor of transcription. Biochem Biophys Res Commun 1998 245:94-100[CrossRef][Medline]
  17. Yan Z, Jetten AM. Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor. J Biol Chem 2000 275:35077-35085[Abstract/Free Full Text]
  18. Fuhrmann G, Chung AC, Jackson KJ, Hummelke G, Baniahmad A, Sutter J, Sylvester I, Scholer HR, Cooney AJ. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell 2001 1:377-387[CrossRef][Medline]
  19. Hummelke GC, Meistrich ML, Cooney AJ. Mouse protamine genes are candidate targets for the novel orphan nuclear receptor, germ cell nuclear factor. Mol Reprod Dev 1998 50:396-405[CrossRef][Medline]
  20. Heinzer C, Süsens U, Schmitz TP, Borgmeyer U. Retinoids induce differential expression and DNA binding of the mouse germ cell nuclear factor in P19 embryonal carcinoma cells. Biol Chem 1998 379:349-359[Medline]
  21. Lei W, Hirose T, Zhang LX, Adachi H, Spinella MJ, Dmitrovsky E, Jetten AM. Cloning of the human orphan receptor germ cell nuclear factor/retinoid receptor-related testis-associated receptor and its differential regulation during embryonal carcinoma cell differentiation. J Mol Endocrinol 1997 18:167-176[Abstract]
  22. O'Brien DA. Isolation, separation and short-term culture of spermatogenic cells. Methods Toxicol 1993 3A:246-264
  23. Strauss WM. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.), Current Protocols for Molecular Biology, vol. 1. New York: Wiley; 1998: 2.2.1–2.2.3
  24. Quertermous T. Plating libraries and transfer to filter membranes. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.), Current Protocols for Molecular Biology, vol. 1. New York: Wiley; 1998: 6.1.1–6.1.4
  25. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 1992 201:134-139[CrossRef][Medline]
  26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 162:156-159[Medline]
  27. Yang G, Gregory CW, Shang Q, O'Brien DA, Zhang YL. Differential expression of CCAAT/enhancer-binding protein-delta (C/EBP{delta}) in rat androgen-dependent tissues and human prostate cancer. J Androl 2001 22:471-480[Abstract]
  28. Fajardo MA, Haugen HS, Clegg CH, Braun RE. Separate elements in the 3' untranslated region of the mouse protamine 1 mRNA regulate translational repression and activation during murine spermatogenesis. Dev Biol 1997 191:42-52[CrossRef][Medline]
  29. Kleene KC, Distel RJ, Hecht NB. Translational regulation and deadenylation of a protamine mRNA during spermiogenesis in the mouse. Dev Biol 1984 105:71-79[CrossRef][Medline]
  30. Schmidt EE, Schibler U. Developmental testis-specific regulation of mRNA levels and mRNA translational efficiencies for TATA-binding protein mRNA isoforms. Dev Biol 1997 184:138-149[CrossRef][Medline]
  31. Bunch DO, Welch JE, Magyar PL, Eddy EM, O'Brien DA. Glyceraldehyde 3-phosphate dehydrogenase-S protein distribution during mouse spermatogenesis. Biol Reprod 1998 58:834-841[Abstract/Free Full Text]
  32. Harlow DE, Lane D. Using Antibodies, A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1999: 215
  33. Greschik H, Wurtz JM, Hublitz P, Köhler F, Moras D, Schüle R. Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor. Mol Cell Biol 1999 19:690-703[Abstract/Free Full Text]
  34. Berget SM. Exon recognition in vertebrate splicing. J Biol Chem 1995 270:2411-2414[Free Full Text]
  35. Pesole G, Liuni S, Grillo G, Licciulli F, Larizza A, Makalowski W, Saccone C. UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs. Nuc Acids Res 2000 28:193-196[Abstract/Free Full Text]
  36. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3' untranslated region. EMBO J 1994 13:1476-1481[Medline]
  37. Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end. Cell 1997 89:597-606[CrossRef][Medline]
  38. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993 72:19-28[CrossRef][Medline]
  39. Wickens M. How the messenger got its tail: addition of poly(A) in the nucleus. Trends Biochem Sci 1990 15:277-281[CrossRef][Medline]
  40. Wallace AM, Dass B, Ravnik SE, Tonk V, Jenkins NA, Gilbert DJ, Copeland NG, MacDonald CC. Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells. Proc Natl Acad Sci U S A 1999 96:6763-6768[Abstract/Free Full Text]
  41. Oakberg EF. A description of spermiogenesis in the mouse and its use in analysis of the cycle of the seminiferous epithelium and germ cell renewal. Am J Anat 1956 99:391-414[CrossRef][Medline]
  42. Bauer UM, Schneider-Hirsch S, Reinhardt S, Benavente R, Maelicke A. The murine nuclear orphan receptor GCNF is expressed in the XY body of primary spermatocytes. FEBS Lett 1998 439:208-214[CrossRef][Medline]
  43. Czaker R. Relative position of constitutive heterochromatin and of nucleolar structures during mouse spermiogenesis. Anat Embryol 1987 175:467-475[CrossRef][Medline]
  44. Süsens U, Borgmeyer U. Genomic structure of the gene for mouse germ cell nuclear factor (GCNF). Genome Biol 2000; 1:research0006.1–0006.3
  45. Süsens U, Borgmeyer U. Genomic structure of the gene for mouse germ-cell nuclear factor (GCNF). II. Comparison with the genomic structure of the human GCNF gene. Genome Biol 2001; 2:research0017.1–0017.7
  46. Kleene KC. A possible meiotic function of the peculiar patterns of gene expression in mammalian spermatogenic cells. Mech Dev 2001 106:3-23[CrossRef][Medline]
  47. Agoulnik IY, Cho Y, Niederberger C, Kieback DG, Cooney AJ. Cloning, expression analysis and chromosomal localization of the human nuclear receptor gene GCNF. FEBS Lett 1998 424:73-78[CrossRef][Medline]
  48. Schneider-Hirsch S, Bauer UM, Heiermann R, Rentrop M, Maelicke A. Cloning of the human NCNF gene. J Recept Signal Transduct Res 1998 18:1-13[Medline]
  49. Chabot B. Directing alternative splicing: cast and scenarios. Trends Genet 1996 12:472-478[CrossRef][Medline]
  50. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev Genet 2002 3:285-298[CrossRef][Medline]
  51. Kleene KC. Patterns of translational regulation in the mammalian testis. Mol Reprod Dev 1996 43:268-281[CrossRef][Medline]
  52. Morales CR, Kwon YK, Hecht NB. Cytoplasmic localization during storage and translation of the mRNAs of transition protein 1 and protamine 1, two translationally regulated transcripts of the mammalian testis. J Cell Sci 1991 100:119-131[Abstract/Free Full Text]
  53. Monesi V. Synthetic activities during spermatogenesis in the mouse. RNA and protein. Exp Cell Res 1965 39:197-224[CrossRef][Medline]
  54. Biggiogera M, Muller S, Courtens JL, Fakan S, Romanini MG. Immunoelectron microscopical distribution of histones H2B and H3 and protamines in the course of mouse spermiogenesis. Microsc Res Tech 1992 20:259-267[CrossRef][Medline]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
B. L. Sartini, H. Wang, W. Wang, C. F. Millette, and D. L. Kilpatrick
Pre-Messenger RNA Cleavage Factor I (CFIm): Potential Role in Alternative Polyadenylation During Spermatogenesis
Biol Reprod, March 1, 2008; 78(3): 472 - 482.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
N. Yan, Y. Lu, H. Sun, D. Tao, S. Zhang, W. Liu, and Y. Ma
A microarray for microRNA profiling in mouse testis tissues
Reproduction, July 1, 2007; 134(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S. Mikawa, T. Morozumi, S.-I. Shimanuki, T. Hayashi, H. Uenishi, M. Domukai, N. Okumura, and T. Awata
Fine mapping of a swine quantitative trait locus for number of vertebrae and analysis of an orphan nuclear receptor, germ cell nuclear factor (NR6A1)
Genome Res., May 1, 2007; 17(5): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al.
International Union of Pharmacology. LXVI. Orphan Nuclear Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836.
[Abstract]